Remove 2017 Remove FDA Remove Insurance Coverage
article thumbnail

Mapping the crisis: How data can help fix America’s growing pharmacy deserts

pharmaphorum

Skip to main content Thursday 12 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

article thumbnail

Wegovy facts and statistics 2025

The Checkup by Singlecare

In 2021, the Food and Drug Administration (FDA) approved Wegovy for weight loss in adults with obesity—or who are overweight with at least one weight-related health condition. A monthly supply of Wegovy can cost more than $1,800 without insurance. According to 2017–2018 data, about 31% of Americans were classified as overweight.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Obesity Medication Use Remains Low Among Children | ADA 2025

Drug Topics

from 2017 to 2020. Glucagon Prescribing Not in Full Alignment With ADA Guidelines | ADA 2025 Ashley Gallagher June 25th 2025 Article The most frequent barriers to access to glucagon include cost, patient health literacy, and insurance coverage.

article thumbnail

How to get Ozempic prescribed for weight loss

The Checkup by Singlecare

Although Ozempic has been approved by the Food and Drug Administration (FDA) since 2017, its status as a household name is relatively recent. Weight loss is an off-label , non-FDA-approved use for Ozempic. The FDA has urged consumers to use caution when taking medication from these compound pharmacies.

article thumbnail

Can I take Ozempic if I’m not diabetic?

The Checkup by Singlecare

Ozempic (semaglutide) is an injectable drug approved by the Food and Drug Administration (FDA) to treat Type 2 diabetes and reduce the risk of major cardiovascular events in people with Type 2 diabetes and known heart disease. Although GLP-1 drugs have been around since 2005, Ozempic was only made available in 2017.

article thumbnail

The US biosimilar market: Predictions for 2021

pharmaphorum

In March 2020, the FDA expanded the biosimilar category to include 90 additional molecules, meaning there are now more therapies that can serve as reference products for biosimilars. The FDA is slated to share its decision on the designation in 2021. Expansion of the biosimilar market in the US & interchangeability.

article thumbnail

How much is NuvaRing (etonogestrel-ethinyl estradiol) without insurance?

The Checkup by Singlecare

Food and Drug Administration (FDA) approved the first generic version of NuvaRing, EluRyng, which contains the same active ingredients. This means your insurance company wants to verify NuvaRing is medically necessary before they agree to cover it. How much does NuvaRing cost without insurance? In December 2019 , the U.S.